Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional Accepts healthy volunteers

A Study of LY3372993 in Participants With Alzheimer's Disease (AD) and Healthy Participants

ClinicalTrials.gov ID: NCT04451408

Public ClinicalTrials.gov record NCT04451408. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 1:00 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3372993 in Participants With Alzheimer's Disease and Healthy Participants

Study identification

NCT ID
NCT04451408
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
139 participants

Conditions and interventions

Interventions

  • LY3372993 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 6, 2020
Primary completion
Nov 17, 2024
Completion
Nov 17, 2024
Last update posted
Mar 27, 2025

2020 – 2024

United States locations

U.S. sites
10
U.S. states
3
U.S. cities
9
Facility City State ZIP Site status
Altasciences Clinical Los Angeles, Inc Cypress California 90630
Collaborative Neuroscience Research, LLC Long Beach California 90806
Accel Research Sites- Clinical Research Unit DeLand Florida 32720
MD Clinical Hallandale Florida 33009
IMIC, Inc. Miami Florida 33176
Ppd Development Orlando Florida 32806-1041
Progressive Medical Research Port Orange Florida 32127
Charter Research The Villages Florida 32162
Synexus Clinical Research US, Inc. The Villages Florida 32162
Covance Dallas Dallas Texas 75247

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04451408, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 27, 2025 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04451408 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →